Lipoxin A4

Lipoxin a4 is a lipid of Fatty Acyls (FA) class. Lipoxin a4 is associated with abnormalities such as Asthma, Cystic Fibrosis, Pneumonia, Obesity and Septicemia. The involved functions are known as Inflammation, Signal, Signal Transduction, Regulation and Metabolic Inhibition. Lipoxin a4 often locates in Immune system, Blood, soluble, Extracellular and Splenic Tissue. The associated genes with Lipoxin A4 are FPR2 gene, Homologous Gene, SAA1 gene, Trp-Lys-Tyr-Met-Val-Met and Annexin 1. The related lipids are Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Lipoxin A4, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Lipoxin A4?

Lipoxin A4 is suspected in Asthma, Cystic Fibrosis, Chagas Cardiomyopathy, Pneumonia, Obesity, Septicemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Lipoxin A4

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Lung Diseases D008171 37 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colitis D003092 69 associated lipids
Per page 10 20 50 100 | Total 53

PubChem Associated disorders and diseases

What pathways are associated with Lipoxin A4

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Lipoxin A4?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Lipoxin A4?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Lipoxin A4?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Lipoxin A4?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Lipoxin A4?

Knock-out

Knock-out are used in the study 'Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.' (Ortiz-Muñoz G et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Lipoxin A4

Download all related citations
Per page 10 20 50 100 | Total 639
Authors Title Published Journal PubMed Link
pmid:
Serhan CN et al. Aspirin-triggered 15-epi-lipoxin A4 and stable analogs on lipoxin A4 are potent inhibitors of acute inflammation. Receptors and pathways. 1999 Adv. Exp. Med. Biol. pmid:10086190
Lin KT et al. Modulation of LTB4 receptor in T-lymphocytes by lipoxin A4 (LXA4) and its role in delayed-type hypersensitivity. 1999 Adv. Exp. Med. Biol. pmid:10086191
Gewirtz AT et al. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. 1999 Am. J. Physiol. pmid:10199831
Levy BD et al. Polyisoprenyl phosphate (PIPP) signaling regulates phospholipase D activity: a 'stop' signaling switch for aspirin-triggered lipoxin A4. 1999 FASEB J. pmid:10224233
Spokas EG et al. Leukotrienes, lipoxins, and hydroxyeicosatetraenoic acids. 1999 Methods Mol. Biol. pmid:10343320
Serhan CN et al. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. 1999 Clin. Chem. Lab. Med. pmid:10353476
Schaldach CM et al. Lipoxin A4: a new class of ligand for the Ah receptor. 1999 Biochemistry pmid:10360957
Hachicha M et al. Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor 1alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis. 1999 J. Exp. Med. pmid:10377187
Clish CB et al. Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10393980
Besse A et al. Prostaglandin E2 regulates macrophage colony stimulating factor secretion by human bone marrow stromal cells. 1999 Biochim. Biophys. Acta pmid:10395955
Chiang N et al. Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. 1999 J. Clin. Invest. pmid:10430612
Kikuta Y et al. Purification and characterization of recombinant rat hepatic CYP4F1. 1999 Arch. Biochem. Biophys. pmid:10486137
Titos E et al. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). 1999 Am. J. Physiol. pmid:10564079
Bratt J and Heimbürger M Prednisolone interferes with neutrophil adhesion and neutrophil mediated endothelial injury. 1999 Scand. J. Rheumatol. pmid:10568428
Filep JG et al. Anti-inflammatory actions of lipoxin A(4) stable analogs are demonstrable in human whole blood: modulation of leukocyte adhesion molecules and inhibition of neutrophil-endothelial interactions. 1999 Blood pmid:10590058
Bandeira-Melo C et al. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. 2000 J. Immunol. pmid:10623853
Godson C et al. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. 2000 J. Immunol. pmid:10657608
Bandeira-Melo C et al. Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. 2000 J. Immunol. pmid:10679058
Sodin-Semrl S et al. Lipoxin A4 inhibits IL-1 beta-induced IL-6, IL-8, and matrix metalloproteinase-3 production in human synovial fibroblasts and enhances synthesis of tissue inhibitors of metalloproteinases. 2000 J. Immunol. pmid:10679106
Pouliot M and Serhan CN Lipoxin A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor-alpha-initiated neutrophil responses and trafficking: novel regulators of a cytokine-chemokine axis relevant to periodontal diseases. 1999 J. Periodont. Res. pmid:10685363
Desplat V et al. Incorporation and effect of arachidonic acid on the growth of human myeloma cell lines. 1999 Mediators Inflamm. pmid:10704149
Chiang N et al. Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation. 2000 J. Exp. Med. pmid:10748237
Tornhamre S et al. 15-Lipoxygenation of leukotriene A(4). Studies Of 12- and 15-lipoxygenase efficiency to catalyze lipoxin formation. 2000 Biochim. Biophys. Acta pmid:10760478
Pouliot M et al. Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. 2000 Biochemistry pmid:10769133
Clish CB et al. Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking. 2000 Ann. N. Y. Acad. Sci. pmid:10818463
Clish CB et al. Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. 2000 J. Biol. Chem. pmid:10837478
Denizot Y et al. Effect of cytokines and lipid mediators on the synthesis of interleukin 1 beta by human bone marrow stromal cells. 2000 Cytokine pmid:10857767
McMahon B et al. Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. 2000 J. Biol. Chem. pmid:10869343
Sanak M et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. 2000 Eur. Respir. J. pmid:10933083
Gewirtz AT and Madara JL Lipoxin-stable analogs: potential therapeutic downregulators of intestinal inflammation. 2000 Ernst Schering Res. Found. Workshop pmid:10943333
Serhan CN and Clish CB Aspirin triggered lipid mediators: novel inhibitors of leucocyte trafficking. 2000 Thorax pmid:10992546
Maderna P et al. Influence of lipoxin A(4) and other lipoxygenase-derived eicosanoids on tissue factor expression. 2000 Am. J. Physiol., Cell Physiol. pmid:11003574
Kang Y et al. Mutations of serine 236-237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. 2000 Biochemistry pmid:11063592
Desplat V et al. Effects of lipoxygenase metabolites of arachidonic acid on the growth of human blood CD34(+) progenitors. 2000 Blood Cells Mol. Dis. pmid:11112380
Gronert K et al. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses. 2001 Am. J. Pathol. pmid:11141472
Kikuta Y et al. Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. 2000 Arch. Biochem. Biophys. pmid:11185557
Serhan CN et al. Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epi-lipoxin A4. 2001 J. Immunol. pmid:11238602
Wada K et al. Inosine monophosphate and aspirin-triggered 15-epi-lipoxin A4 act in concert to regulate neutrophil trafficking: additive actions of two new endogenous anti-inflammatory mediators. 2001 J. Hematother. Stem Cell Res. pmid:11276361
Fierro IM and Serhan CN Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins. 2001 Braz. J. Med. Biol. Res. pmid:11323741
Levy BD et al. Lipid mediator class switching during acute inflammation: signals in resolution. 2001 Nat. Immunol. pmid:11429545
Wardle N New vistas in anti-inflammatory therapy. 2001 Nephron pmid:11474222
McMahon B et al. Lipoxins: revelations on resolution. 2001 Trends Pharmacol. Sci. pmid:11478982
Goh J et al. Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. 2001 J. Immunol. pmid:11509622
Qiu FH et al. Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. 2001 FASEB J. pmid:11687510
Goulet JL et al. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 2001 J. Immunol. pmid:11714834
Aliberti J et al. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. 2002 Nat. Immunol. pmid:11743584
Vachier I et al. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. 2002 Biochem. Biophys. Res. Commun. pmid:11779156
Fierro IM et al. Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A(4) and lipoxin A(4). 2002 J. Pharmacol. Exp. Ther. pmid:11805195
Resnati M et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:11818541
Gewirtz AT et al. Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. 2002 J. Immunol. pmid:11994483
Aliberti J and Sher A Positive and negative regulation of pathogen induced dendritic cell function by G-protein coupled receptors. 2002 Mol. Immunol. pmid:12009566
Bonnans C et al. Lipoxins are potential endogenous antiinflammatory mediators in asthma. 2002 Am. J. Respir. Crit. Care Med. pmid:12045128
Maderna P et al. Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. 2002 Am. J. Pathol. pmid:12057930
Tam FW Role of selectins in glomerulonephritis. 2002 Clin. Exp. Immunol. pmid:12100015
Levy BD et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). 2002 Nat. Med. pmid:12172542
Peters-Golden M 'Good' lipids for asthma. 2002 Nat. Med. pmid:12205450
Romano M et al. Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. 2002 Lab. Invest. pmid:12218086
Vaughn MW et al. Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene. 2002 J. Immunol. pmid:12218158
McMahon B et al. Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. 2002 FASEB J. pmid:12223454
József L et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit peroxynitrite formation, NF-kappa B and AP-1 activation, and IL-8 gene expression in human leukocytes. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12235371
Planagumà A et al. Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor alpha-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. 2002 FASEB J. pmid:12368230
Fiorucci S et al. Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 2002 Gastroenterology pmid:12404234
Christophe T et al. Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. 2002 Scand. J. Immunol. pmid:12410796
Aliberti J et al. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. 2002 J. Exp. Med. pmid:12417634
Kucharzik T et al. Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. 2003 Am. J. Physiol., Cell Physiol. pmid:12456400
Schottelius AJ et al. An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. 2002 J. Immunol. pmid:12471142
Bonnans C et al. Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium. 2003 J. Biol. Chem. pmid:12500974
Van Dyke TE and Serhan CN Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. 2003 J. Dent. Res. pmid:12562878
Gangemi S et al. Physical exercise increases urinary excretion of lipoxin A4 and related compounds. 2003 J. Appl. Physiol. pmid:12588790
Kantarci A et al. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. 2003 J. Periodontol. pmid:12593599
Fierro IM et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. 2003 J. Immunol. pmid:12594298
Souza MH et al. Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12637254
Titos E et al. Aspirin-triggered 15-epi-lipoxin A4 biosynthesis in rat liver cells. 2002 Adv. Exp. Med. Biol. pmid:12664586
Bandeira-Melo C et al. Inhibition of allergen-induced eosinophil migration by lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4. 2002 Adv. Exp. Med. Biol. pmid:12664587
Filep JG et al. Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 modulate adhesion molecule expression on human leukocytes in whole blood and inhibit neutrophil-endothelial cell adhesion. 2002 Adv. Exp. Med. Biol. pmid:12664589
Devchand PR et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense. 2003 FASEB J. pmid:12665478
Goh J et al. Lipoxins: pro-resolution lipid mediators in intestinal inflammation. 2003 Gastroenterology pmid:12671901
Fiorucci S et al. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. 2003 FASEB J. pmid:12709408
Chiang N et al. A novel rat lipoxin A4 receptor that is conserved in structure and function. 2003 Br. J. Pharmacol. pmid:12746227
Levy BD et al. Lipoxins and aspirin-triggered lipoxins in airway responses. 2003 Adv. Exp. Med. Biol. pmid:12751730
Ariel A et al. Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. 2003 J. Immunol. pmid:12794159
Wallace JL and Fiorucci S A magic bullet for mucosal protection...and aspirin is the trigger! 2003 Trends Pharmacol. Sci. pmid:12871661
Fiorucci S et al. Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. 2003 Br. J. Pharmacol. pmid:12890715
Bae YS et al. Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. 2003 Mol. Pharmacol. pmid:12920210
Phillips ED et al. Synthesis of methyl (5S,6R,7E,9E,11Z,13E,15S)-16-(4-fluorophenoxy)-5,6,15-trihydroxy-7,9,11,13-hexadecatetraenoate, an analogue of 15R-lipoxin A4. 2003 Bioorg. Med. Chem. Lett. pmid:12951097
Fiore S et al. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. 1992 J. Biol. Chem. pmid:1322894
Sharp GJ et al. Lipoxin-induced migration of fish leukocytes. 1992 J. Leukoc. Biol. pmid:1331277
Kowalski ML et al. Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. 2003 J. Allergy Clin. Immunol. pmid:13679808
Meini S et al. Pharmacologic and neurochemical evidence for the activation of capsaicin-sensitive sensory nerves by lipoxin A4 in guinea pig bronchus. 1992 Am. Rev. Respir. Dis. pmid:1384407
Badr KF 15-Lipoxygenase products as leukotriene antagonists: therapeutic potential in glomerulonephritis. 1992 Kidney Int. Suppl. pmid:1405359
Katoh T et al. Renal hemodynamic actions of lipoxins in rats: a comparative physiological study. 1992 Am. J. Physiol. pmid:1415572
Serhan CN et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. 2003 J. Immunol. pmid:14662892
Wallace JL et al. Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:14665439
Boutet P et al. Imbalance between lipoxin A4 and leukotriene B4 in chronic mastitis-affected cows. 2003 J. Dairy Sci. pmid:14672172
Wikström E et al. Lipoxin A4-induced release of thromboxane in the guinea-pig lung: studies of its characteristics using lipoxin A4-methyl ester. 1992 J Lipid Mediat pmid:1467461
Bannenberg GL et al. Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. 2004 J. Exp. Med. pmid:14970178
Sodin-Semrl S et al. Lipoxin A4 counteracts synergistic activation of human fibroblast-like synoviocytes. 2004 Jan-Apr Int J Immunopathol Pharmacol pmid:15000862
Gilroy DW et al. A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. 2004 FASEB J. pmid:15003994
Guilford WJ et al. Novel 3-oxa lipoxin A4 analogues with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo. 2004 J. Med. Chem. pmid:15056011